Chad Oh

Chad Oh currently serves as the Chief Medical Officer at AEON Biopharma, Inc., a position held since June 2021. Prior to this role, Chad Oh was VP of Clinical Development at The Weinberg Group from August 2018 to June 2021. Between May 2008 and June 2021, Chad Oh operated as a Clinical and Biotech Expert in the Biotech and Pharma sector. Earlier in the career, Chad Oh was the Chief of Allergy and Immunology and an Associate Professor at Harbor-UCLA Medical Center and UCLA School of Medicine from June 1995 to May 2008.